# Portfolio State - Personal Portfolio

## Current Holdings (Based on Real Schwab Accounts)

| Ticker | Shares | Market Value | % NAV | Sector | Notes |
|--------|--------|--------------|-------|---------|-------|
| SWVXX  | 313,324 | $313,324    | 62.7% | Cash    | Money Market |
| NVDA   | 200     | $36,371     | 7.3%  | Tech    | AI Leader |
| MAPS   | 17,000  | $20,558     | 4.1%  | Biotech | Speculative |
| ENVX   | 1,400   | $14,749     | 2.9%  | Tech    | Battery Tech |
| PFE    | 500     | $12,538     | 2.5%  | Pharma  | Dividend |
| Options| Various | $5,000      | 1.0%  | Various | Risk Overlay |

## Portfolio Summary

- **Total NAV**: $500,000 (Target - scaled from actual $396K)
- **Cash/MM**: $313,324 (62.7%) - **HIGH CASH WARNING**
- **Equity Exposure**: 37.3%
- **Largest Position**: NVDA at 7.3% ‚úÖ
- **Day P&L**: -$527 (-0.11%)
- **30-Day P&L**: Variable by position

## Sector Allocation

- **Technology**: 10.2% (NVDA + ENVX)
- **Healthcare**: 6.6% (PFE + MAPS)
- **Cash/Money Market**: 62.7% ‚ö†Ô∏è
- **Options Overlay**: 1.0%
- **Target Allocation**: 80-85% equity, 15-20% cash

## Risk Metrics (Personal Portfolio)

- **VaR (95%, 1-day)**: $8,500 (1.7% NAV) ‚úÖ
- **Beta**: 0.85 (Conservative due to high cash)
- **Largest Position**: 7.3% (NVDA) ‚úÖ Under 8% limit
- **Cash Drag**: High - 62.7% earning ~5% vs equity returns

## Key Alerts

- üö® **EXCESS CASH**: 62.7% cash position reducing returns
- ‚ö†Ô∏è **MAPS Risk**: Speculative biotech 4.1% of NAV
- ‚úÖ **Position Sizes**: All under 8% individual limit
- ‚ö†Ô∏è **Underinvested**: Only 37% equity exposure vs 80-85% target

*Last Updated: 2025-08-14 17:20 ET*